FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment

[FDA]

FDA approved Leqembi (lecanemab-irmb) for treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease.


Baca selengkapnya di : http://www.fda.gov...